(Q36114436)

Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12 August 2017

Ruilope LM

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15868118

retrieved

12 August 2017

language of work or name

1 reference

1 April 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15868118

retrieved

12 August 2017

volume

42 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15868118

retrieved

12 August 2017

page(s)

S33-41

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15868118

retrieved

12 August 2017

exact match

https://scigraph.springernature.com/pub.10.1007/s00592-005-0179-x

0 references

cites work

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/S0140-6736(03)12229-5

Identifiers

DOI

10.1007/S00592-005-0179-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15868118

retrieved

12 August 2017

PubMed publication ID

15868118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15868118

retrieved

12 August 2017

(Q36114436)

Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)